Genzyme recalls transplant drug Mass High Tech Thymoglobulin is given to kidney transplant patients to treat acute rejection of the organ, and is given in conjunction with immunosuppression therapy. The recall was launched on August 2, and the affected lots are as follows: C0062C01 C0072C01 ... |
